- PZU reported a net income of 1.47 billion zloty for the second quarter, which is a 23% increase year-over-year. However, this figure was below the estimated 1.59 billion zloty.
- Insurance sales rose by 5.6% year-over-year, reaching 7.69 billion zloty, surpassing the estimate of 7.5 billion zloty based on two analyst estimates.
- The operating profit for PZU in the second quarter was 4.06 billion zloty, representing a 15% increase from the previous year. This was, however, below the expected 4.25 billion zloty.
- Looking at the first half of the year, PZU’s net income was 3.23 billion zloty, marking a substantial 32% year-over-year increase.
- Analyst recommendations for PZU include 4 buy ratings, 7 hold ratings, and 1 sell rating.
A look at Powszechny Zaklad Ubezpieczen Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
When looking at the long-term outlook for Powszechny Zaklad Ubezpieczen, the Smartkarma Smart Scores provide a positive overall view. With high scores across various factors such as Value, Dividend, Growth, and Momentum, the company appears well-positioned for future success in the insurance sector. Although the Resilience score is slightly lower, the balanced ratings suggest a solid foundation for sustained performance.
Powszechny Zaklad Ubezpieczen SA specializes in property and casualty insurance, offering a diverse range of non-life insurance products including fire and automobile insurance, along with a division dedicated to life insurance. With strong scores in key areas like Value and Momentum, the company may be on a path towards continued growth and prosperity in the insurance industry, making it an intriguing option for long-term investors seeking stability and potential returns.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
